Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang, F, Moum, B, Haug, J B, Tolås, P, Breder, O, Aubert, E, Høie, O, Søberg, T, Flaaten, B, Farup, P, Berge, T
Published in The American journal of gastroenterology (01.02.1997)
Get more information
Published in The American journal of gastroenterology (01.02.1997)
Journal Article
Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection : Experience from clinical practice in a population with a high frequency of metronidazole resistance
LERANG, F, MOUM, B, RAGNHILDSTVEIT, E, SANDVEI, P. K, TOLAS, P, WHIST, J. E, HENRIKSEN, M, HAUG, J. B, BERGE, T
Published in The American journal of gastroenterology (01.02.1998)
Published in The American journal of gastroenterology (01.02.1998)
Get full text
Journal Article
A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study
Lerang, F, Moum, B, Ragnhildstveit, E, Haug, J B, Hauge, T, Tolås, P, Aubert, E, Henriksen, M, Efskind, P S, Nicolaysen, K, Søberg, T, Odegaard, A, Berge, T
Published in The American journal of gastroenterology (01.04.1997)
Get more information
Published in The American journal of gastroenterology (01.04.1997)
Journal Article
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy
Lerang, F, Moum, B, Haug, J B, Berge, T, Tolås, P, Sandvei, P K, Torp, R, Tønnesen, T
Published in Scandinavian journal of gastroenterology (1997)
Published in Scandinavian journal of gastroenterology (1997)
Get more information
Journal Article